StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
K33.ST$0.02-0.42%
Fair $0.02+0.0%

K33.ST

K33 AB (publ)

Financial Services / Capital MarketsStockholm

$0.02

-0.00 (-0.42%)

Fairly Valued+0.0%Fair Value $0.02Fund rank 31/100 · Data gapFallback financials|
SA 29/D
F-Score: 2/9
Low Profitability

Book/ROE base 3Y

n/d

n/d CAGR · P/B n/d

Book/ROE base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 100% · confianza 20%

Book/ROE escenarios

weak_data · book/share n/d · quality 0.0/100

Data gap 31/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 32/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

29/100

D

Piotroski

2/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); financial Book/ROE targets are disabled until manually verified. ROE is -51.0%, below the 5% threshold
Thesis & Journal · K33.STLocal privado en este navegador · K33 AB (publ)
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$343M

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

-51.0%

↓

Gross Margin

0.4%

↓

Debt/Equity

0.07

↓
52-Week Range$0
$0$0

TradingView lightweight chart

K33.ST price, volumen y niveles de valoración

Último $0.023Periodo -100.0%
Fair value: $0.023

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+97.4%

FCF CAGR

—

FCF margin

-7.5%

FCF / Net income

2.46x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $2.21B · net income $-67.7M · FCF $-166.8M

2022-FY → 2025-FY

Gross margin

0.4%+3.3% pts

Operating margin

-3.1%+30.1% pts

Net margin

-3.1%+29.7% pts

FCF margin

-7.5%+10.5% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$2.21B$2.21B$958.5M$154.1M$287.2M
Net Income$-67.7M$-67.7M$-4.2M$-90.0M$-94.2M
EBITDA$-5.2M$-5.2M$7.2M$-12.3M$-37.4M
EPS-0.00-0.00-0.00-0.01-0.01
Gross Margin0.4%0.4%1.6%-5.8%-2.9%
Operating Margin-3.1%-3.1%-0.1%-46.0%-33.2%
Net Margin-3.1%-3.1%-0.4%-58.4%-32.8%
Balance Sheet
Debt/Equity0.070.070.29-2174.350.37
Current Ratio1.241.24———
Cash Flow
Free Cash Flow$-166.8M$-166.8M$-22.1M$-1.9M$-51.9M
Returns
ROE-51.0%-51.0%-14.1%529394.1%-132.2%
Valuation
EV/EBITDA——76.11——
P/B2.582.5818.53—3.88
Growth & Yield
Revenue Growth130.7%130.7%522.0%-46.4%—
EPS Growth-1261.7%-1261.7%96.4%10.8%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -53.0%

Total return

-53.0%

Start / end P/E

n/dx → n/dx

EPS bridge

-0.00 → -0.00

Residual

-53.0%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-53.0%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.